Ikarian Capital, LLC Connect Biopharma Holdings LTD Transaction History

Ikarian Capital, LLC

  • $573 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.8 - $1.65 $366,686 - $756,290
-458,358 Reduced 67.62%
219,501 $283,000
Q1 2022

May 13, 2022
BUY
$2.46 - $5.92 $1.02 Million - $2.46 Million
415,622 Added 158.49%
677,859 $2.05 Million
Q4 2021

Feb 14, 2022
BUY
$4.26 - $23.33 $1.12 Million - $6.12 Million
262,237 New
262,237 $1.35 Million

Others Institutions Holding CNTB

# of Institutions
12
Shares Held
3.05M
Call Options Held
0
Put Options Held
0
View Full List

About Connect Biopharma Holdings Ltd

CNTB Quotes by TradingView
  • Ticker CNTB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,015,800
  • Market Cap $55M
  • Description
  • Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...
More about CNTB
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email